Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Specific Population

Filter by Infection

HIV (remove)
Hepatitis C (1)

Filter by Resource Category

Research summary (remove)

Search results

Current filters: HIV drugs, HIV, Treatment, Research summary

104 search results

3
4
5
6
7

Isentress HD in clinical trials: From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage
Isentress HD—a new once-daily formulation of raltegravir approved in Canada: From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage
Doravirine vs. darunavir: From TreatmentUpdate 220
2017, CATIE
Research summary - Webpage
A new nuke in the works—GS-9131: From TreatmentUpdate 220
2017, CATIE
Research summary - Webpage
Bictegravir in the body—preliminary information about drug interactions: From TreatmentUpdate 220
2017, CATIE
Research summary - Webpage
Bictegravir—an emerging integrase inhibitor: From TreatmentUpdate 220
2017, CATIE
Research summary - Webpage
The capsid inhibitor—a new class to enter clinical trials: From TreatmentUpdate 220
2017, CATIE
Research summary - Webpage
New drugs, new hope and possible timelines: From TreatmentUpdate 220
2017, CATIE
Research summary - Webpage
Dolutegravir in women: From TreatmentUpdate 218
2016, CATIE
Research summary - Webpage
Stribild in women: From TreatmentUpdate 218
2016, CATIE
Research summary - Webpage

3
4
5
6
7

Events

Conference on Retroviruses and Opportunistic Infections (CROI)

International Antiviral Society – USA
March 6 to 10, 2021
Online

Canadian Liver Meeting 2021

Canadian Association for the Study of the Liver, the Canadian Network on Hepatitis C (CanHepC) and the Canadian Association of Hepatology Nurses
May 2 to May 5, 2021
Online

CAHR 2021

Canadian Association for HIV Research
May 5 to 7, 2021
Online

IAS Conference on HIV Science

International AIDS Society
July 18 to 21, 2021
Online

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.